FR-190809 is a nonadrenotoxic and orally efficacious inhibitor of acyl-CoA:cholesterol O-acyltransferase (ACAT) (IC50: 45 nM).

FR-190809 inhibits foam cell formation (IC50: 215 nM)[1].

215589-63-2

C29H34FN3O6S2

603.73

FR-190809

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years